SEC Filing Update: #CLRB Cellectar Biosciences, Inc. : $2.62

Sector: Healthcare | YTD: 🔽 -24.50% The SEC disclosed Today (14-AUG-2026) that StemPoint Capital LP has INCREASED #CLRB Shares by 138.28% 🟢 BALYASNY ASSET MANAGEMENT LLC also newly bought shares on the same day. * Previous Holdings: 354.94K Shares * Current Holdings: 845.74K Shares * Increase+490.80K * Increased(%)+138.28% * Ownership: 9.9% * Estimated Investment Value: $1.26M https://www.thinksabio.com/reports/isr/CLRB 📌 Institutional activity in the last 30 days for #CLRB: • EMPERY ASSET MANAGEMENT, LP – Newly bought 864,090 shares (04-AUG-2026) • BLEICHROEDER LP – Increased holdings by 519,621 shares (13-AUG-2026) • BALYASNY ASSET MANAGEMENT LLC – Newly bought 798,382 shares (14-AUG-2026)